apraclonidine has been researched along with Age-Related Macular Degeneration in 1 studies
apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "05 mL of bevacizumab or ranibizumab), that were divided into five groups, group 1: no intraocular pressure (IOP)-lowering medication (n=50); group 2: apraclonidine 1 % one drop 2 hours prior to IVI (n=50); group 3: acetazolamide 250 mg 2 hours prior (n=50); group 4: fixed combination brimonidine+timolol (n=30); group 5: fixed combination dorzolamide+timolol (n=30)." | 5.16 | [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections]. ( Dot, C; El Chehab, H; Giraud, JM; Le Corre, A; Ract-Madoux, G; Swalduz, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Chehab, H | 1 |
| Le Corre, A | 1 |
| Giraud, JM | 1 |
| Ract-Madoux, G | 1 |
| Swalduz, B | 1 |
| Dot, C | 1 |
1 trial available for apraclonidine and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
Topics: Acetazolamide; Aged; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimon | 2012 |